Journal of Oncology / 2012 / Article / Fig 5

Research Article

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma

Figure 5

Expression of VEGF in tumor xenografts. Concentration of VEGF levels in tumor lysates measured by ELISA and expressed as pg/mL normalized to protein content in the tumor lysate. (a) There were significant differences in human VEGF levels between treatment groups (* 𝑃 < 0 . 0 5 ). The lowest human VEGF concentration was detected in control tumors while the highest VEGF concentration was detected in combined treatment group, showing that TekdeltaFc and LDM CTX therapy both individually and in combination significantly upregulated melanoma cell VEGF expression. (b) There were no significant differences in murine VEGF between treatment groups ( 𝑃 > 0 . 0 5 ).
794172.fig.005a
(a)
794172.fig.005b
(b)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.